These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 25649470)

  • 1. Interferon and ribavirin combination therapy are linked to severe indirect hyperbilirubinemia in patients with nt-211G > A variant of UGT1A1 gene.
    Biziya N; Gidaagaya S; Namdag B; Yang SS
    J Formos Med Assoc; 2015 Nov; 114(11):1147-8. PubMed ID: 25649470
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mutation analysis of UGT1A1 gene in patients with unconjugated hyperbilirubinemia].
    Sun SC; Zhou ZM; Chen QR; Peng YS; Tu CQ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):425-8. PubMed ID: 23926009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gilbert's syndrome and antiviral therapy of hepatitis C.
    Deterding K; Grüngreiff K; Lankisch TO; Potthoff A; Bahr MJ; Manns MP; Wedemeyer H; Strassburg CP
    Ann Hepatol; 2009; 8(3):246-50. PubMed ID: 19841506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.
    Mori S; Terada K; Ueki Y
    Mod Rheumatol; 2012 Aug; 22(4):515-23. PubMed ID: 21993917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short communication: UGT1A1*28 variant allele is a predictor of severe hyperbilirubinemia in HIV-infected patients on HAART in southern Brazil.
    Turatti L; Sprinz E; Lazzaretti RK; Kuhmmer R; Agnes G; Silveira JM; Basso RP; Pinheiro CA; Silveira MF; de Almeida S; Ribeiro JP; Mattevi VS
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1015-8. PubMed ID: 22050734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: a quantitative analysis.
    Chen Z; Su D; Ai L; Jiang X; Wu C; Xu Q; Wang X; Fan Z
    Gene; 2014 Nov; 552(1):32-8. PubMed ID: 25200497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease.
    de Vries HS; Te Morsche RH; Jenniskens K; Peters WH; de Jong DJ
    J Crohns Colitis; 2012 Jun; 6(5):597-602. PubMed ID: 22398043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UGT1A1 genetic analysis as a diagnostic aid for individuals with unconjugated hyperbilirubinemia.
    Skierka JM; Kotzer KE; Lagerstedt SA; O'Kane DJ; Baudhuin LM
    J Pediatr; 2013 Jun; 162(6):1146-52, 1152.e1-2. PubMed ID: 23290513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic factors influencing severe atazanavir-associated hyperbilirubinemia in a population with low UDP-glucuronosyltransferase 1A1*28 allele frequency.
    Park WB; Choe PG; Song KH; Jeon JH; Park SW; Kim HB; Kim NJ; Oh MD; Choe KW
    Clin Infect Dis; 2010 Jul; 51(1):101-6. PubMed ID: 20504240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.
    Sugatani J; Yamakawa K; Yoshinari K; Machida T; Takagi H; Mori M; Kakizaki S; Sueyoshi T; Negishi M; Miwa M
    Biochem Biophys Res Commun; 2002 Mar; 292(2):492-7. PubMed ID: 11906189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of unconjugated hyperbilirubinemia in Taiwanese.
    Huang CS
    J Biomed Sci; 2005; 12(3):445-50. PubMed ID: 15965581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab.
    Lee JS; Wang J; Martin M; Germer S; Kenwright A; Benayed R; Spleiss O; Platt A; Pilson R; Hemmings A; Weinblatt ME; Kaplowitz N; Krasnow J
    Pharmacogenet Genomics; 2011 Jul; 21(7):365-74. PubMed ID: 21412181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir.
    Boyd MA; Srasuebkul P; Ruxrungtham K; Mackenzie PI; Uchaipichat V; Stek M; Lange JM; Phanuphak P; Cooper DA; Udomuksorn W; Miners JO
    Pharmacogenet Genomics; 2006 May; 16(5):321-9. PubMed ID: 16609363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection.
    Sidhu-Malik NK; Kaplan AL
    J Drugs Dermatol; 2003 Oct; 2(5):570-3. PubMed ID: 14558408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variations in the UDP-glucuronosyltransferase 1A1 gene for the development of unconjugated hyperbilirubinemia in Taiwanese.
    Huang YY; Huang MJ; Yang SS; Teng HC; Huang CS
    Pharmacogenomics; 2008 Sep; 9(9):1229-35. PubMed ID: 18781851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in serum bilirubin in HIV/hepatitis-C virus-coinfected patients on atazanavir therapy following initiation of pegylated-interferon and ribavirin.
    Rodríguez-Nóvoa S; Morello J; González M; Vispo E; Barreiro P; González-Pardo G; Jiménez-Nácher I; Gonzalez-Lahoz J; Soriano V
    AIDS; 2008 Nov; 22(18):2535-7. PubMed ID: 19005277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of hematological abnormalities in patients with chronic hepatitis C treated with interferon and ribavirin.
    Nachnani JS; Rao GA; Bulchandani D; Pandya PK; Alba LM
    Ann Hematol; 2010 Feb; 89(2):121-5. PubMed ID: 19565241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronosyltransferase promoter polymorphism in Iranian neonates with idiopathic hyperbilirubinemia.
    Kaveh M; Esmailnia T; Nayeri F; Nili F; Davari Tanha F; Ghajarzdeh M
    Acta Med Iran; 2013; 51(11):789-92. PubMed ID: 24390949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphisms in Thai neonates with hyperbilirubinemia.
    Prachukthum S; Nunnarumit P; Pienvichit P; Chuansumrit A; Songdej D; Kajanachumpol S; Pakakasama S; Hongeng S
    Acta Paediatr; 2009 Jul; 98(7):1106-10. PubMed ID: 19397531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.
    Kumar KS; Russo MW; Borczuk AC; Brown M; Esposito SP; Lobritto SJ; Jacobson IM; Brown RS
    Am J Gastroenterol; 2002 Sep; 97(9):2432-40. PubMed ID: 12358269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.